Business Context and Reporting Period
Marchex, Inc. (MCHX) filed this Form 8-K on July 1, 2026, to report the consummation of the acquisition of 100% of the outstanding shares of Archenia, Inc. Archenia is a performance-based marketing technology company specializing in AI-verified customer qualification and acquisition. The transaction was approved by stockholders at a special meeting held on the same date.
Key Financial Metrics and Transaction Terms
- Consideration: Marchex issued $10 million in convertible promissory notes to the sellers.
- Note Terms: The notes bear 6% interest, payable in three equal tranches at 12, 18, and 24 months. They are convertible into Class B common stock at $1.80 per share.
- Contingent Consideration: Up to 2 million shares of Class B common stock may be issued for each of the first two 12-month periods post-closing if Archenia exceeds prior revenue/Adjusted EBITDA benchmarks and meets integration/retention targets.
- Financial Statements: The filing incorporates audited financial statements for Archenia for the year ended December 31, 2025, and unaudited statements for the quarter ended March 31, 2026, but does not provide specific revenue or profit figures in the text of this report.
Material Changes and Voting Results
The primary material change is the addition of Archenia's assets and business operations to Marchex. The transaction required and received approval under two voting standards:
- Simple Majority Vote: Approved by approximately 99.9% of votes cast (151,454,493 For vs. 25,074 Against).
- Majority of the Minority Vote: Approved by approximately 99.9% of disinterested votes (32,537,021 For vs. 25,074 Against).
Outlook, Risks, and Contingencies
Future financial obligations are contingent on Archenia's performance relative to the 12-month period prior to closing. Risks include the potential dilution from the issuance of up to 4 million additional shares if performance targets are met. The notes contain customary events of default, including failure to pay or insolvency, which could accelerate repayment obligations. The filing does not provide specific management commentary on future revenue guidance beyond the transaction mechanics.
Investor Verification Checklist
- Review Exhibit 99.1 and 99.2 for Archenia's specific audited and unaudited financial performance metrics.
- Examine Exhibit 99.3 for the unaudited pro forma condensed financial information to understand the combined entity's projected financial position.
- Verify the specific revenue and Adjusted EBITDA thresholds required to trigger the issuance of the 2 million shares per period.
- Confirm the exact terms of the convertible notes in Exhibit 4.1, including conversion mechanics and default provisions.